Evidence map›Paper›PMID 29202108›Full record

ArticleHeliyon2017

Alissa Greenbaum, Charles Wiggins, Angela Lw Meisner, Manuel Rojo, Anita Y Kinney, Ashwani Rajput

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2023
    Article
  3. Geographic differences in community oncology provider and practice location characteristics in the central United States.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022
    Article
  4. Treatment patterns for metastatic colorectal cancer in Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Observational
  5. Genomic Profiling forJCO precision oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alissa GreenbaumDepartment of Surgery, University of New Mexico, Albuquerque, NM, United States.
Charles WigginsNew Mexico Tumor Registry, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
Angela Lw MeisnerNew Mexico Tumor Registry, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
Manuel RojoUniversity of New Mexico School of Medicine, University of New Mexico, Albuquerque, NM, United States.
Anita Y KinneyDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
Ashwani RajputDepartment of Surgery, University of New Mexico, Albuquerque, NM, United States.
University of New Mexico · USUNM Comprehensive Cancer Center

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
NCI NIH HHS P30 CA118100
6 · The paper itself

Abstract

introductionAmerican Society of Clinical Oncology (ASCO) guidelines recommend that all patients with metastatic colorectal cancer (mCRC) receive KRAS testing to guide anti-EGFR monoclonal antibody treatment. The aim of this study was to assess for disparities in

methodsThe New Mexico Tumor Registry (NMTR), a population-based cancer registry participating in the National Cancer Institute's Surveillance, Epidemiology and End Results program, was queried to identify all incident cases of CRC diagnosed among New Mexico residents from 2010 to 2013.

resultsSix hundred thirty-seven patients were diagnosed with mCRC from 2010-2013. As expected,

conclusionAge and geographic disparities exist in the rates of

Indexed as

Clinical geneticsHealth sciencesOncology

Identifiers

PMID29202108
PMCPMC5701808
OpenAlexW2768135593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.